-
Clinical Interventions in Aging
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
Case report
(2711) Views (845) Full article downloads
Authors: Dimitrios Karagiannis, Ilias Georgalas, Ioannis Ladas, Parikakis Eustratios, Panagiotis Mitropoulos
Published Date December 2008
Volume 2009:4 Pages 63 - 65
DOI: http://dx.doi.org/10.2147/CIA.S4803
Dimitrios Karagiannis1, Ilias Georgalas2, Ioannis Ladas2, Parikakis Eustratios1, Panagiotis Mitropoulos1
1Second Department of Ophthalmiatrion Eye Hospital, NHS, Athens, Greece; 2Department of Ophthalmology, “G.Genimatas” General Hospital, Athens, Greece
Abstract: A 65-year-old lady presented with decreased vision in her left eye (LE). Best corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic juxtafoveal retinal telangiectasis associated with subretinal neovascularization and she was treated with intravitreal ranibizumab every month for three months in the LE. After four months, her BCVA increased to 3/10. Fluorescein angiography (FA) showed minimal leakage and optical coherence tomography (OCT) confirmed absence of intra- or subretinal fluid in the macula. Examinations were repeated monthly for another 12 months and showed no recurrence. Intravitreal ranibizumab showed promising results for subretinal neovascularization due to idiopathic juxtafoveal retinal telangiectasis. A prospective study with large series of patients and controls may be necessary in order to determine the effectiveness of this treatment.
Keywords: idiopathic juxtafoveal retinal telangiectasis, ranibizumab, subretinal neovascularization
Other articles by Dr Ilias Georgalas
Acquired color vision and visual field defects in patients with ocular hypertension and early glaucomaAngioid streaks, clinical course, complications, and current therapeutic management
Contemporary aspects in the prognosis of traumatic hyphemas
Cytomegalovirus retinitis presenting as vasculitis in a patient with Wegener’s granulomatosis
Foveal thickness after phacoemulsification as measured by optical coherence tomography
Lens-induced glaucoma in the elderly
Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
Preliminary results following the use of a fixed combination of timolol–brimonidine in patients with ocular hypertension and primary open-angle glaucoma
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
- Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies
- Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
- The cognitive impact of anticholinergics: A clinical review




